You are on page 1of 46

Medical biostatistics Fourth Edition

Indrayan
Visit to download the full and correct content document:
https://textbookfull.com/product/medical-biostatistics-fourth-edition-indrayan/
More products digital (pdf, epub, mobi) instant
download maybe you interests ...

Research Methods for Medical Graduates 1st Edition


Abhaya Indrayan

https://textbookfull.com/product/research-methods-for-medical-
graduates-1st-edition-abhaya-indrayan/

Biostatistics for Medical and Biomedical Practitioners


Second Edition Julien I. E. Hoffman

https://textbookfull.com/product/biostatistics-for-medical-and-
biomedical-practitioners-second-edition-julien-i-e-hoffman/

Medical terminology complete! Fourth Edition Bruce


Wingerd

https://textbookfull.com/product/medical-terminology-complete-
fourth-edition-bruce-wingerd/

Biological and medical aspects of electromagnetic


fields Fourth Edition Barnes

https://textbookfull.com/product/biological-and-medical-aspects-
of-electromagnetic-fields-fourth-edition-barnes/
Basic & Clinical Biostatistics Susan White

https://textbookfull.com/product/basic-clinical-biostatistics-
susan-white/

Epidemiology and Biostatistics An Introduction to


Clinical Research Bryan Kestenbaum

https://textbookfull.com/product/epidemiology-and-biostatistics-
an-introduction-to-clinical-research-bryan-kestenbaum/

Intuitive Biostatistics: A Nonmathematical Guide to


Statistical Thinking 4th Edition Harvey Motulsky

https://textbookfull.com/product/intuitive-biostatistics-a-
nonmathematical-guide-to-statistical-thinking-4th-edition-harvey-
motulsky/

Computational and Methodological Statistics and


Biostatistics Contemporary Essays in Advancement
Andriëtte Bekker

https://textbookfull.com/product/computational-and-
methodological-statistics-and-biostatistics-contemporary-essays-
in-advancement-andriette-bekker/

Biostatistics and Computer-based Analysis of Health


Data using R 1st Edition Christophe Lalanne

https://textbookfull.com/product/biostatistics-and-computer-
based-analysis-of-health-data-using-r-1st-edition-christophe-
lalanne/
Medical Biostatistics
Fourth Edition
Editor-in-Chief
Shein-Chung Chow, Ph.D., Professor, Department of Biostatistics and Bioinformatics,
Duke University School of Medicine, Durham, North Carolina

Series Editors
Byron Jones, Biometrical Fellow, Statistical Methodology, Integrated Information Sciences,
Novartis Pharma AG, Basel, Switzerland
Jen-pei Liu, Professor, Division of Biometry, Department of Agronomy,
National Taiwan University, Taipei, Taiwan
Karl E. Peace, Georgia Cancer Coalition, Distinguished Cancer Scholar, Senior Research Scientist
and Professor of Biostatistics, Jiann-Ping Hsu College of Public Health,
Georgia Southern University, Statesboro, Georgia
Bruce W. Turnbull, Professor, School of Operations Research and Industrial Engineering,
Cornell University, Ithaca, New York

Published Titles
Adaptive Design Methods in Clinical Basic Statistics and Pharmaceutical
Trials, Second Edition Statistical Applications, Second Edition
Shein-Chung Chow and Mark Chang James E. De Muth
Adaptive Designs for Sequential Bayesian Adaptive Methods for
Treatment Allocation Clinical Trials
Alessandro Baldi Antognini Scott M. Berry, Bradley P. Carlin,
and Alessandra Giovagnoli J. Jack Lee, and Peter Muller
Adaptive Design Theory and Bayesian Analysis Made Simple:
Implementation Using SAS and R, An Excel GUI for WinBUGS
Second Edition Phil Woodward
Mark Chang Bayesian Designs for Phase I–II
Advanced Bayesian Methods for Clinical Trials
Medical Test Accuracy Ying Yuan, Hoang Q. Nguyen,
Lyle D. Broemeling and Peter F. Thall
Analyzing Longitudinal Clinical Trial Data: Bayesian Methods for Measures
A Practical Guide of Agreement
Craig Mallinckrodt and Ilya Lipkovich Lyle D. Broemeling
Applied Biclustering Methods for Big Bayesian Methods for Repeated Measures
and High-Dimensional Data Using R Lyle D. Broemeling
Adetayo Kasim, Ziv Shkedy, Bayesian Methods in Epidemiology
Sebastian Kaiser, Sepp Hochreiter, Lyle D. Broemeling
and Willem Talloen
Bayesian Methods in Health Economics
Applied Meta-Analysis with R Gianluca Baio
Ding-Geng (Din) Chen and Karl E. Peace
Bayesian Missing Data Problems: EM,
Applied Surrogate Endpoint Evaluation Data Augmentation and Noniterative
Methods with SAS and R Computation
Ariel Alonso, Theophile Bigirumurame, Ming T. Tan, Guo-Liang Tian,
Tomasz Burzykowski, Marc Buyse, and Kai Wang Ng
Geert Molenberghs, Leacky Muchene,
Nolen Joy Perualila, Ziv Shkedy,
and Wim Van der Elst
Published Titles

Bayesian Modeling in Bioinformatics Clinical Trial Optimization Using R


Dipak K. Dey, Samiran Ghosh, Alex Dmitrienko and Erik Pulkstenis
and Bani K. Mallick Cluster Randomised Trials:
Benefit-Risk Assessment in Second Edition
Pharmaceutical Research and Richard J. Hayes and Lawrence H. Moulton
Development Computational Methods in Biomedical
Andreas Sashegyi, James Felli, Research
and Rebecca Noel Ravindra Khattree and Dayanand N. Naik
Benefit-Risk Assessment Methods in Computational Pharmacokinetics
Medical Product Development: Bridging Anders Källén
Qualitative and Quantitative Assessments
Confidence Intervals for Proportions
Qi Jiang and Weili He
and Related Measures of Effect Size
Bioequivalence and Statistics in Clinical Robert G. Newcombe
Pharmacology, Second Edition
Controversial Statistical Issues in
Scott Patterson and Byron Jones
Clinical Trials
Biosimilar Clinical Development: Shein-Chung Chow
Scientific Considerations and New
Data Analysis with Competing Risks
Methodologies
and Intermediate States
Kerry B. Barker, Sandeep M. Menon,
Ronald B. Geskus
Ralph B. D’Agostino, Sr., Siyan Xu, and Bo Jin
Data and Safety Monitoring Committees
Biosimilars: Design and Analysis of
in Clinical Trials, Second Edition
Follow-on Biologics
Jay Herson
Shein-Chung Chow
Design and Analysis of Animal Studies
Biostatistics: A Computing Approach
in Pharmaceutical Development
Stewart J. Anderson
Shein-Chung Chow and Jen-pei Liu
Cancer Clinical Trials: Current and
Design and Analysis of Bioavailability
Controversial Issues in Design and
and Bioequivalence Studies, Third Edition
Analysis
Shein-Chung Chow and Jen-pei Liu
Stephen L. George, Xiaofei Wang,
and Herbert Pang Design and Analysis of Bridging Studies
Jen-pei Liu, Shein-Chung Chow,
Causal Analysis in Biomedicine and
and Chin-Fu Hsiao
Epidemiology: Based on Minimal
Sufficient Causation Design & Analysis of Clinical Trials for
Mikel Aickin Economic Evaluation & Reimbursement:
An Applied Approach Using SAS & STATA
Clinical and Statistical Considerations in
Iftekhar Khan
Personalized Medicine
Claudio Carini, Sandeep Menon, and Mark Chang Design and Analysis of Clinical Trials
for Predictive Medicine
Clinical Trial Data Analysis Using R
Shigeyuki Matsui, Marc Buyse,
Ding-Geng (Din) Chen and Karl E. Peace
and Richard Simon
Clinical Trial Data Analysis Using R and SAS,
Design and Analysis of Clinical Trials with
Second Edition
Time-to-Event Endpoints
Ding-Geng (Din) Chen, Karl E. Peace,
Karl E. Peace
and Pinggao Zhang
Design and Analysis of Non-Inferiority Trials
Clinical Trial Methodology
Mark D. Rothmann, Brian L. Wiens,
Karl E. Peace and Ding-Geng (Din) Chen
and Ivan S. F. Chan
Published Titles
Difference Equations with Public Health Inference Principles for Biostatisticians
Applications Ian C. Marschner
Lemuel A. Moyé and Asha Seth Kapadia Interval-Censored Time-to-Event Data:
DNA Methylation Microarrays: Methods and Applications
Experimental Design and Statistical Ding-Geng (Din) Chen, Jianguo Sun,
Analysis and Karl E. Peace
Sun-Chong Wang and Arturas Petronis Introductory Adaptive Trial Designs:
DNA Microarrays and Related Genomics A Practical Guide with R
Techniques: Design, Analysis, and Mark Chang
Interpretation of Experiments Joint Models for Longitudinal and Time-
David B. Allison, Grier P. Page, to-Event Data: With Applications in R
T. Mark Beasley, and Jode W. Edwards Dimitris Rizopoulos
Dose Finding by the Continual Measures of Interobserver Agreement
Reassessment Method and Reliability, Second Edition
Ying Kuen Cheung Mohamed M. Shoukri
Dynamical Biostatistical Models Medical Biostatistics, Fourth Edition
Daniel Commenges and A. Indrayan
Hélène Jacqmin-Gadda
Meta-Analysis in Medicine and
Elementary Bayesian Biostatistics Health Policy
Lemuel A. Moyé Dalene Stangl and Donald A. Berry
Emerging Non-Clinical Biostatistics in Methods in Comparative Effectiveness
Biopharmaceutical Development and Research
Manufacturing Constantine Gatsonis and Sally C. Morton
Harry Yang
Mixed Effects Models for the Population
Empirical Likelihood Method in Approach: Models, Tasks, Methods
Survival Analysis and Tools
Mai Zhou Marc Lavielle
Essentials of a Successful Biostatistical Modeling to Inform Infectious Disease
Collaboration Control
Arul Earnest Niels G. Becker
Exposure–Response Modeling: Methods Modern Adaptive Randomized Clinical
and Practical Implementation Trials: Statistical and Practical Aspects
Jixian Wang Oleksandr Sverdlov
Frailty Models in Survival Analysis Monte Carlo Simulation for the
Andreas Wienke Pharmaceutical Industry: Concepts,
Fundamental Concepts for New Clinical Algorithms, and Case Studies
Trialists Mark Chang
Scott Evans and Naitee Ting
Multiregional Clinical Trials for
Generalized Linear Models: A Bayesian Simultaneous Global New Drug
Perspective Development
Dipak K. Dey, Sujit K. Ghosh, and Joshua Chen and Hui Quan
Bani K. Mallick
Multiple Testing Problems in
Handbook of Regression and Modeling: Pharmaceutical Statistics
Applications for the Clinical and Alex Dmitrienko, Ajit C. Tamhane,
Pharmaceutical Industries and Frank Bretz
Daryl S. Paulson
Published Titles

Noninferiority Testing in Clinical Trials: Statistical Design and Analysis of Clinical


Issues and Challenges Trials: Principles and Methods
Tie-Hua Ng Weichung Joe Shih and Joseph Aisner
Optimal Design for Nonlinear Response Statistical Design and Analysis of
Models Stability Studies
Valerii V. Fedorov and Sergei L. Leonov Shein-Chung Chow
Patient-Reported Outcomes: Statistical Evaluation of Diagnostic
Measurement, Implementation and Performance: Topics in ROC Analysis
Interpretation Kelly H. Zou, Aiyi Liu, Andriy Bandos,
Joseph C. Cappelleri, Kelly H. Zou, Lucila Ohno-Machado, and Howard Rockette
Andrew G. Bushmakin, Jose Ma. J. Alvir, Statistical Methods for Clinical Trials
Demissie Alemayehu, and Tara Symonds Mark X. Norleans
Quantitative Evaluation of Safety in Drug Statistical Methods for Drug Safety
Development: Design, Analysis and Robert D. Gibbons and Anup K. Amatya
Reporting
Statistical Methods for Healthcare
Qi Jiang and H. Amy Xia
Performance Monitoring
Quantitative Methods for Alex Bottle and Paul Aylin
HIV/AIDS Research
Statistical Methods for Immunogenicity
Cliburn Chan, Michael G. Hudgens, and
Assessment
Shein-Chung Chow
Harry Yang, Jianchun Zhang, Binbing Yu,
Quantitative Methods for Traditional and Wei Zhao
Chinese Medicine Development
Statistical Methods in Drug Combination
Shein-Chung Chow
Studies
Randomized Clinical Trials of Wei Zhao and Harry Yang
Nonpharmacological Treatments
Statistical Testing Strategies in the
Isabelle Boutron, Philippe Ravaud,
Health Sciences
and David Moher
Albert Vexler, Alan D. Hutson,
Randomized Phase II Cancer and Xiwei Chen
Clinical Trials
Statistics in Drug Research:
Sin-Ho Jung
Methodologies and Recent
Repeated Measures Design with Developments
Generalized Linear Mixed Models for Shein-Chung Chow and Jun Shao
Randomized Controlled Trials
Statistics in the Pharmaceutical Industry,
Toshiro Tango
Third Edition
Sample Size Calculations for Clustered Ralph Buncher and Jia-Yeong Tsay
and Longitudinal Outcomes in Clinical
Survival Analysis in Medicine and
Research
Genetics
Chul Ahn, Moonseong Heo,
Jialiang Li and Shuangge Ma
and Song Zhang
Theory of Drug Development
Sample Size Calculations in Clinical
Eric B. Holmgren
Research, Third Edition
Shein-Chung Chow, Jun Shao, Hansheng Translational Medicine: Strategies and
Wang, and Yuliya Lokhnygina Statistical Methods
Dennis Cosmatos and Shein-Chung Chow
Statistical Analysis of Human Growth
and Development
Yin Bun Cheung
http://taylorandfrancis.com
Medical Biostatistics
Fourth Edition

Abhaya Indrayan
Rajeev Kumar Malhotra
CRC Press
Taylor & Francis Group
6000 Broken Sound Parkway NW, Suite 300
Boca Raton, FL 33487-2742

© 2018 by Taylor & Francis Group, LLC


CRC Press is an imprint of Taylor & Francis Group, an Informa business

No claim to original U.S. Government works

Printed on acid-free paper

International Standard Book Number-13: 978-1-4987-9953-9 (Hardback)

This book contains information obtained from authentic and highly regarded sources. Reasonable efforts have been made to publish reliable data and informa-
tion, but the author and publisher cannot assume responsibility for the validity of all materials or the consequences of their use. The authors and publishers have
attempted to trace the copyright holders of all material reproduced in this publication and apologize to copyright holders if permission to publish in this form
has not been obtained. If any copyright material has not been acknowledged please write and let us know so we may rectify in any future reprint.

Except as permitted under U.S. Copyright Law, no part of this book may be reprinted, reproduced, transmitted, or utilized in any form by any electronic,
mechanical, or other means, now known or hereafter invented, including photocopying, microfilming, and recording, or in any information storage or retrieval
system, without written permission from the publishers.

For permission to photocopy or use material electronically from this work, please access www.copyright.com (http://www.copyright.com/) or contact the
Copyright Clearance Center, Inc. (CCC), 222 Rosewood Drive, Danvers, MA 01923, 978-750-8400. CCC is a not-for-profit organization that provides licenses
and registration for a variety of users. For organizations that have been granted a photocopy license by the CCC, a separate system of payment has been arranged.

Trademark Notice: Product or corporate names may be trademarks or registered trademarks, and are used only for identification and explanation without intent
to infringe.
Visit the Taylor & Francis Web site at
http://www.taylorandfrancis.com
and the CRC Press Web site at
http://www.crcpress.com
Contents

Summary Tables................................................................................................................................................................................... xxix


Preface...................................................................................................................................................................................................xxxv
Frequently Used Notations............................................................................................................................................................. xxxvii

1. Medical Uncertainties.......................................................................................................................................................................1
1.1 Uncertainties in Health and Disease.....................................................................................................................................2
1.1.1 Uncertainties due to Intrinsic Variation..................................................................................................................2
1.1.1.1 Biologic Variability......................................................................................................................................2
1.1.1.2 Genetic Variability......................................................................................................................................3
1.1.1.3 Variation in Behavior and Other Host Factors........................................................................................3
1.1.1.4 Environmental Variability.........................................................................................................................3
1.1.1.5 Sampling Fluctuations................................................................................................................................3
1.1.2 Natural Variation in Assessment..............................................................................................................................4
1.1.2.1 Observer Variability....................................................................................................................................4
1.1.2.2 Variability in Treatment Strategies...........................................................................................................4
1.1.2.3 Instrument and Laboratory Variability...................................................................................................4
1.1.2.4 Imperfect Tools............................................................................................................................................4
1.1.2.5 Incomplete Information on the Patient....................................................................................................5
1.1.2.6 Poor Compliance with the Regimen.........................................................................................................5
1.1.3 Knowledge Limitations..............................................................................................................................................5
1.1.3.1 Epistemic Uncertainties..............................................................................................................................5
1.1.3.2 Chance Variability.......................................................................................................................................6
1.1.3.3 Diagnostic, Therapeutic, and Prognostic Uncertainties........................................................................6
1.1.3.4 Predictive and Other Uncertainties..........................................................................................................6
1.2 Uncertainties in Medical Research........................................................................................................................................7
1.2.1 Empiricism in Medical Research..............................................................................................................................7
1.2.1.1 Laboratory Experiments.............................................................................................................................7
1.2.1.2 Clinical Trials...............................................................................................................................................7
1.2.1.3 Surgical Procedures....................................................................................................................................7
1.2.1.4 Epidemiological Research..........................................................................................................................8
1.2.2 Elements of Minimizing the Impact of Uncertainties on Research....................................................................8
1.2.2.1 Proper Design..............................................................................................................................................8
1.2.2.2 Improved Medical Methods......................................................................................................................8
1.2.2.3 Analysis and Synthesis...............................................................................................................................9
1.3 Uncertainties in Health Planning and Evaluation..............................................................................................................9
1.3.1 Health Situation Analysis..........................................................................................................................................9
1.3.1.1 Identification of the Specifics of the Problem........................................................................................10
1.3.1.2 Magnitude of the Problem.......................................................................................................................10
1.3.1.3 Health Infrastructure...............................................................................................................................10
1.3.1.4 Feasibility of Remedial Steps...................................................................................................................11
1.3.2 Evaluation of Health Programs..............................................................................................................................11
1.4 Management of Uncertainties: About This Book..............................................................................................................11
1.4.1 Contents of the Book................................................................................................................................................12
1.4.1.1 Chapters......................................................................................................................................................12
1.4.1.2 Limitations and Strengths.......................................................................................................................13
1.4.1.3 New in the Fourth Edition.......................................................................................................................14
1.4.1.4 Unique Contribution of This Book.........................................................................................................14

ix
x Contents

1.4.2 Salient Features of the Text......................................................................................................................................15


1.4.2.1 System of Notations..................................................................................................................................15
1.4.2.2 Guide Chart of the Biostatistical Methods............................................................................................16
References..........................................................................................................................................................................................16
Exercises.............................................................................................................................................................................................16

2. Basics of Medical Studies..............................................................................................................................................................17


2.1 Study Protocol........................................................................................................................................................................17
2.1.1 Problem, Objectives, and Hypotheses...................................................................................................................17
2.1.1.1 Problem.......................................................................................................................................................17
2.1.1.2 Broad and Specific Objectives.................................................................................................................18
2.1.1.3 Hypotheses.................................................................................................................................................18
2.1.2 Protocol Content........................................................................................................................................................19
2.2 Types of Medical Studies......................................................................................................................................................21
2.2.1 Elements of a Study Design.....................................................................................................................................22
2.2.2 Basic Types of Study Design...................................................................................................................................22
2.2.2.1 Descriptive Studies...................................................................................................................................23
2.2.2.2 Analytical Studies and Their Basic Types.............................................................................................24
2.2.3 Choosing a Design....................................................................................................................................................24
2.2.3.1 Recommended Design for Particular Setups........................................................................................24
2.2.3.2 Choice of Design by Level of Evidence..................................................................................................25
2.3 Data Collection.......................................................................................................................................................................27
2.3.1 Nature of Data...........................................................................................................................................................27
2.3.1.1 Factual, Knowledge-Based, and Opinion-Based Data.........................................................................27
2.3.1.2 Method of Obtaining the Data................................................................................................................27
2.3.2 Tools of Data Collection...........................................................................................................................................28
2.3.2.1 Existing Records........................................................................................................................................28
2.3.2.2 Questionnaires and Schedules................................................................................................................28
2.3.2.3 Likert Scale.................................................................................................................................................29
2.3.2.4 Guttman Scale............................................................................................................................................30
2.3.3 Pretesting and Pilot Study.......................................................................................................................................30
2.4 Nonsampling Errors and Other Biases...............................................................................................................................31
2.4.1 Nonresponse..............................................................................................................................................................31
2.4.2 Variety of Biases to Guard Against........................................................................................................................31
2.4.2.1 List of Biases...............................................................................................................................................31
2.4.2.2 Steps for Minimizing Bias........................................................................................................................35
References..........................................................................................................................................................................................35
Exercises.............................................................................................................................................................................................36

3. Sampling Methods..........................................................................................................................................................................37
3.1 Sampling Concepts................................................................................................................................................................37
3.1.1 Advantages and Limitations of Sampling.............................................................................................................37
3.1.1.1 Sampling Fluctuations..............................................................................................................................37
3.1.1.2 Advantages of Sampling..........................................................................................................................38
3.1.1.3 Limitations of Sampling...........................................................................................................................38
3.1.2 Some Special Terms Used in Sampling.................................................................................................................38
3.1.2.1 Unit of Inquiry and Sampling Unit........................................................................................................38
3.1.2.2 Sampling Frame........................................................................................................................................39
3.1.2.3 Parameters and Statistics.........................................................................................................................39
3.1.2.4 Sample Size................................................................................................................................................39
3.1.2.5 Nonrandom and Random Sampling......................................................................................................39
3.1.2.6 Sampling Weight.......................................................................................................................................39
Contents xi

3.2 Common Methods of Random Sampling...........................................................................................................................40


3.2.1 Simple Random Sampling.......................................................................................................................................40
3.2.2 Stratified Random Sampling...................................................................................................................................41
3.2.3 Multistage Random Sampling................................................................................................................................43
3.2.4 Cluster Random Sampling......................................................................................................................................43
3.2.5 Systematic Random Sampling................................................................................................................................45
3.2.6 Choice of the Method of Random Sampling........................................................................................................46
3.3 Some Other Methods of Sampling......................................................................................................................................46
3.3.1 Other Random Methods of Sampling....................................................................................................................46
3.3.1.1 Probability Proportional to Size Sampling............................................................................................47
3.3.1.2 Area Sampling...........................................................................................................................................47
3.3.1.3 Inverse Sampling.......................................................................................................................................47
3.3.1.4 Consecutive Subjects Attending a Clinic...............................................................................................48
3.3.1.5 Sequential Sampling.................................................................................................................................48
3.3.2 Nonrandom Methods of Sampling........................................................................................................................48
3.3.2.1 Convenience Sample.................................................................................................................................48
3.3.2.2 Other Types of Purposive Samples.........................................................................................................49
References..........................................................................................................................................................................................49
Exercises.............................................................................................................................................................................................49

4. Designs for Observational Studies..............................................................................................................................................51


4.1 Some Basic Concepts.............................................................................................................................................................51
4.1.1 Antecedent and Outcome........................................................................................................................................51
4.1.2 Confounders..............................................................................................................................................................52
4.1.3 Effect Size...................................................................................................................................................................53
4.1.4 Ecological Studies.....................................................................................................................................................53
4.2 Prospective Studies................................................................................................................................................................53
4.2.1 Variations of Prospective Studies...........................................................................................................................54
4.2.1.1 Cohort Study..............................................................................................................................................54
4.2.1.2 Longitudinal Study...................................................................................................................................54
4.2.1.3 Repeated Measures Study........................................................................................................................55
4.2.2 Selection of Subjects for a Prospective Study.......................................................................................................55
4.2.2.1 Comparison Group in a Prospective Study...........................................................................................55
4.2.3 Potential Biases in Prospective Studies.................................................................................................................56
4.2.3.1 Selection Bias.............................................................................................................................................56
4.2.3.2 Bias due to Loss in Follow-Up.................................................................................................................56
4.2.3.3 Assessment Bias and Errors....................................................................................................................56
4.2.3.4 Bias due to Change in the Status............................................................................................................57
4.2.3.5 Confounding Bias.....................................................................................................................................57
4.2.3.6 Post Hoc Bias..............................................................................................................................................57
4.2.4 Merits and Demerits of Prospective Studies.........................................................................................................57
4.2.4.1 Merits of Prospective Studies..................................................................................................................57
4.2.4.2 Demerits of Prospective Studies.............................................................................................................57
4.3 Retrospective Studies............................................................................................................................................................58
4.3.1 Case–Control Design...............................................................................................................................................58
4.3.1.1 Nested Case–Control Design..................................................................................................................59
4.3.2 Selection of Cases and Controls..............................................................................................................................59
4.3.2.1 Selection of Cases......................................................................................................................................60
4.3.2.2 Selection of Controls.................................................................................................................................60
4.3.2.3 Sampling Methods in Retrospective Studies........................................................................................60
4.3.2.4 Confounders and Matching.....................................................................................................................60
4.3.3 Merits and Demerits of Case–Control Studies.....................................................................................................61
4.3.3.1 Merits of Case–Control Studies..............................................................................................................61
4.3.3.2 Demerits of Case–Control Studies..........................................................................................................61
xii Contents

4.4 Cross-Sectional Studies.........................................................................................................................................................62


4.4.1 Selection of Subjects for a Cross-Sectional Study................................................................................................62
4.4.2 Merits and Demerits of Cross-Sectional Studies..................................................................................................62
4.4.2.1 Demerits of Cross-Sectional Studies......................................................................................................62
4.4.2.2 Merits of Cross-Sectional Studies...........................................................................................................63
4.5 Comparative Performance of Prospective, Retrospective, and Cross-Sectional Studies............................................63
4.5.1 Comparative Features and Performance Comparison....................................................................................... 64
4.5.2 Reporting Results of Observational Studies: STROBE........................................................................................65
References..........................................................................................................................................................................................66
Exercises.............................................................................................................................................................................................66

5. Medical Experiments......................................................................................................................................................................67
5.1 Basic Features of Medical Experiments..............................................................................................................................67
5.1.1 Statistical Principles of Experimentation..............................................................................................................68
5.1.1.1 Control Group............................................................................................................................................68
5.1.1.2 Randomization..........................................................................................................................................68
5.1.1.3 Replication..................................................................................................................................................69
5.1.2 Advantages and Limitations of Experiments.......................................................................................................69
5.1.2.1 Advantages.................................................................................................................................................69
5.1.2.2 Limitations.................................................................................................................................................70
5.2 Design of Experiments..........................................................................................................................................................70
5.2.1 Classical Designs: One-Way, Two-Way, and Factorial.........................................................................................71
5.2.1.1 One-Way Design........................................................................................................................................71
5.2.1.2 Two-Way Design........................................................................................................................................71
5.2.1.3 Interaction..................................................................................................................................................72
5.2.1.4 K-Way and Factorial Experiments...........................................................................................................73
5.2.2 Some Common Unconventional Designs..............................................................................................................74
5.2.2.1 Repeated Measures Design......................................................................................................................74
5.2.2.2 Crossover Design......................................................................................................................................75
5.2.2.3 Other Complex Designs...........................................................................................................................76
5.3 Choice of Sampling of Units for Laboratory Experiments...............................................................................................76
5.3.1 Choice of Experimental Unit...................................................................................................................................77
5.3.2 Sampling Methods in Laboratory Experiments...................................................................................................77
5.3.3 Choosing a Design of Experiment.........................................................................................................................77
5.3.4 Pharmacokinetic Studies.........................................................................................................................................78
References..........................................................................................................................................................................................78
Exercises.............................................................................................................................................................................................79

6. Clinical Trials...................................................................................................................................................................................81
6.1 Therapeutic Trials..................................................................................................................................................................81
6.1.1 Phases of a Clinical Trial.........................................................................................................................................81
6.1.1.1 Phase I Trial................................................................................................................................................81
6.1.1.2 Phase II Trial..............................................................................................................................................82
6.1.1.3 Phase III Trial.............................................................................................................................................82
6.1.1.4 Phase IV: Postmarketing Surveillance...................................................................................................83
6.1.2 Randomized Controlled Trials: Selection of Subjects.........................................................................................83
6.1.2.1 Selection of Participants for RCT............................................................................................................83
6.1.2.2 Control Group in a Clinical Trial............................................................................................................84
6.1.3 Randomization and Matching................................................................................................................................85
6.1.3.1 Randomization..........................................................................................................................................86
6.1.3.2 Matching.....................................................................................................................................................86
6.1.4 Methods of Random Allocation.............................................................................................................................87
6.1.4.1 Allocation Out of a Large Number of Available Subjects...................................................................87
6.1.4.2 Random Allocation of Consecutive Patients Coming to a Clinic......................................................87
6.1.4.3 Block, Cluster, and Stratified Randomization.......................................................................................88
Contents xiii

6.1.5 Blinding and Masking.............................................................................................................................................89


6.1.5.1 Blinding......................................................................................................................................................89
6.1.5.2 Concealment of Allocation.......................................................................................................................89
6.1.5.3 Masking......................................................................................................................................................90
6.2 Issues in Clinical Trials.........................................................................................................................................................90
6.2.1 Outcome Assessment...............................................................................................................................................90
6.2.1.1 Specification of End Points or Outcome.................................................................................................90
6.2.1.2 Causal Inference........................................................................................................................................91
6.2.1.3 Side Effects.................................................................................................................................................91
6.2.1.4 Effectiveness versus Efficacy...................................................................................................................92
6.2.1.5 Pragmatic Trials.........................................................................................................................................92
6.2.2 Various Equivalences in Clinical Trials.................................................................................................................92
6.2.2.1 Superiority, Equivalence, and Noninferiority Trials............................................................................92
6.2.2.2 Therapeutic Equivalence and Bioequivalence......................................................................................93
6.2.3 Designs for Clinical Trials.......................................................................................................................................94
6.2.3.1 n-of-1, Up-and-Down, and Sequential Designs....................................................................................94
6.2.3.2 Choosing a Design for a Clinical Trial...................................................................................................95
6.2.4 Designs with Interim Appraisals...........................................................................................................................95
6.2.4.1 Designs with Provision to Stop Early.....................................................................................................96
6.2.4.2 Adaptive Designs......................................................................................................................................96
6.2.5 Biostatistical Ethics for Clinical Trials...................................................................................................................97
6.2.5.1 Equipoise....................................................................................................................................................97
6.2.5.2 Ethical Cautions.........................................................................................................................................98
6.2.5.3 Statistical Considerations in a Multicentric Trial.................................................................................98
6.2.5.4 Multiple Treatments with Different Outcomes in the Same Trial......................................................98
6.2.5.5 Size of the Trial..........................................................................................................................................99
6.2.5.6 Compliance................................................................................................................................................99
6.2.6 Reporting the Results of a Clinical Trial...............................................................................................................99
6.2.6.1 CONSORT Statement................................................................................................................................99
6.2.6.2 Registration of Trials and Open Access...............................................................................................100
6.3 Trials Other than for Therapeutics....................................................................................................................................101
6.3.1 Clinical Trials for Diagnostic and Prophylactic Modalities.............................................................................101
6.3.1.1 Diagnostic Trials......................................................................................................................................101
6.3.1.2 Prophylactic Trials in Clinics.................................................................................................................102
6.3.2 Field Trials for Screening, Prophylaxis, and Vaccines.......................................................................................102
6.3.2.1 Screening Trials.......................................................................................................................................102
6.3.2.2 Prophylactic Trials in the Field..............................................................................................................102
6.3.2.3 Vaccine Trials...........................................................................................................................................103
6.3.3 Issues in Field Trials...............................................................................................................................................103
6.3.3.1 Randomization and Blinding in Field Trials.......................................................................................103
6.3.3.2 Designs for Field Trials...........................................................................................................................104
References........................................................................................................................................................................................104
Exercises...........................................................................................................................................................................................105

7. Numerical Methods for Representing Variation....................................................................................................................107


7.1 Types of Measurement........................................................................................................................................................107
7.1.1 Nominal, Metric, and Ordinal Scales..................................................................................................................107
7.1.1.1 Nominal Scale..........................................................................................................................................107
7.1.1.2 Metric Scale..............................................................................................................................................108
7.1.1.3 Ordinal Scale............................................................................................................................................108
7.1.1.4 Grouping of a Metric Scale (Categorizing Continuous Measurements).........................................109
7.1.2 Other Classifications of the Types of Measurement.......................................................................................... 110
7.1.2.1 Discrete and Continuous Variables...................................................................................................... 110
7.1.2.2 Qualitative and Quantitative Data....................................................................................................... 111
7.1.2.3 Stochastic and Deterministic Variables............................................................................................... 111
xiv Contents

7.2 Tabular Presentation............................................................................................................................................................ 111


7.2.1 Contingency Tables and Frequency Distribution..............................................................................................112
7.2.1.1 Empty Cells..............................................................................................................................................113
7.2.1.2 Problems in Preparing a Contingency Table on Metric Data...........................................................113
7.2.1.3 Features of a Table...................................................................................................................................113
7.2.2 Other Types of Statistical Tables........................................................................................................................... 114
7.2.2.1 Multiple Responses Tables..................................................................................................................... 114
7.2.2.2 Statistical Tables.......................................................................................................................................115
7.2.2.3 What Is a Good Statistical Table?..........................................................................................................115
7.3 Rates and Ratios...................................................................................................................................................................115
7.3.1 Proportion, Rate, and Ratio...................................................................................................................................115
7.3.1.1 Proportion................................................................................................................................................ 116
7.3.1.2 Rate............................................................................................................................................................ 116
7.3.1.3 Ratio.......................................................................................................................................................... 116
7.4 Central and Other Locations..............................................................................................................................................117
7.4.1 Central Values: Mean, Median, and Mode..........................................................................................................117
7.4.1.1 Understanding Mean, Median, and Mode.......................................................................................... 118
7.4.1.2 Calculation in the Case of Grouped Data............................................................................................ 118
7.4.1.3 Which Central Value to Use?.................................................................................................................120
7.4.1.4 Geometric Mean......................................................................................................................................121
7.4.1.5 Harmonic Mean.......................................................................................................................................121
7.4.2 Other Locations: Quantiles...................................................................................................................................122
7.4.2.1 Quantiles in Ungrouped Data...............................................................................................................123
7.4.2.2 Quantiles in Grouped Data....................................................................................................................123
7.4.2.3 Interpretation of Quantiles....................................................................................................................124
7.5 Measuring Variability.........................................................................................................................................................125
7.5.1 Variance and Standard Deviation........................................................................................................................126
7.5.1.1 Variance and Standard Deviation in Ungrouped Data.....................................................................126
7.5.1.2 Variance and Standard Deviation in Grouped Data..........................................................................128
7.5.1.3 Variance of Sum or Difference of Two Measurements......................................................................128
7.5.1.4 Measuring Variation in Skewed and Nominal Data: Interquartile Range and Variation Ratio......... 128
7.5.2 Coefficient of Variation..........................................................................................................................................129
References........................................................................................................................................................................................131
Exercises...........................................................................................................................................................................................131

8. Presentation of Variation by Figures: Data Visualization....................................................................................................133


8.1 Graphs for Frequency Distribution...................................................................................................................................133
8.1.1 Histogram and Its Variants...................................................................................................................................134
8.1.1.1 Histogram.................................................................................................................................................134
8.1.1.2 Stem-and-Leaf Plot..................................................................................................................................134
8.1.1.3 Line Histogram and Dot Plot................................................................................................................136
8.1.2 Polygon and Its Variants........................................................................................................................................136
8.1.2.1 Frequency Polygon..................................................................................................................................136
8.1.2.2 Area Diagram..........................................................................................................................................136
8.1.3 Frequency Curve.....................................................................................................................................................136
8.2 Pie, Bar, and Line Diagrams...............................................................................................................................................136
8.2.1 Pie Diagram.............................................................................................................................................................137
8.2.1.1 Useful Features of a Pie Diagram.........................................................................................................138
8.2.1.2 Donut Diagram........................................................................................................................................138
8.2.2 Bar Diagram.............................................................................................................................................................138
8.2.3 Scatter and Line Diagrams....................................................................................................................................140
8.2.3.1 Scatter Diagram.......................................................................................................................................140
8.2.3.2 Bubble Chart............................................................................................................................................140
8.2.3.3 Line Diagram...........................................................................................................................................142
8.2.3.4 Complex Line Diagram..........................................................................................................................142
Contents xv

8.2.4 Choice and Cautions in Visual Display of Data.................................................................................................143


8.2.5 Mixed and Three-Dimensional Diagrams..........................................................................................................144
8.2.5.1 Mixed Diagram........................................................................................................................................144
8.2.5.2 Box-and-Whiskers Plot...........................................................................................................................144
8.2.5.3 Three-Dimensional Diagram................................................................................................................145
8.2.5.4 Biplot.........................................................................................................................................................146
8.2.5.5 Nomogram...............................................................................................................................................146
8.3 Special Diagrams in Health and Medicine......................................................................................................................146
8.3.1 Diagrams Used in Public Health..........................................................................................................................147
8.3.1.1 Epidemic Curve.......................................................................................................................................148
8.3.1.2 Lexis Diagram..........................................................................................................................................148
8.3.2 Diagrams Used in Individual Care and Research.............................................................................................148
8.3.2.1 Growth Chart...........................................................................................................................................148
8.3.2.2 Partogram.................................................................................................................................................150
8.3.2.3 Dendrogram.............................................................................................................................................150
8.3.2.4 Radar Graph.............................................................................................................................................150
8.4 Charts and Maps..................................................................................................................................................................152
8.4.1 Charts.......................................................................................................................................................................152
8.4.1.1 Schematic Chart......................................................................................................................................152
8.4.1.2 Health Infographics................................................................................................................................152
8.4.1.3 Pedigree Chart.........................................................................................................................................153
8.4.2 Maps.........................................................................................................................................................................154
8.4.2.1 Spot Map...................................................................................................................................................154
8.4.2.2 Thematic Choroplethic Map..................................................................................................................154
8.4.2.3 Cartogram................................................................................................................................................154
References........................................................................................................................................................................................156
Exercises...........................................................................................................................................................................................156

9. Some Quantitative Aspects of Medicine..................................................................................................................................159


9.1 Some Epidemiological Measures of Health and Disease...............................................................................................159
9.1.1 Epidemiological Indicators of Neonatal Health.................................................................................................160
9.1.1.1 Birth Weight.............................................................................................................................................160
9.1.1.2 Apgar Score.............................................................................................................................................. 161
9.1.2 Epidemiological Indicators of Growth in Children........................................................................................... 161
9.1.2.1 Weight-for-Age, Height-for-Age, and Weight-for-Height.................................................................. 161
9.1.2.2 Z-Scores and Percent of Median...........................................................................................................162
9.1.2.3 T-Score.......................................................................................................................................................163
9.1.2.4 Growth Velocity.......................................................................................................................................163
9.1.2.5 Skinfold Thickness..................................................................................................................................164
9.1.2.6 Other Indicators of Growth...................................................................................................................164
9.1.3 Epidemiological Indicators of Adolescent Health..............................................................................................164
9.1.3.1 Growth in Height and Weight in Adolescence...................................................................................164
9.1.3.2 Sexual Maturity Rating..........................................................................................................................165
9.1.4 Epidemiological Indicators of Adult Health.......................................................................................................165
9.1.4.1 Obesity......................................................................................................................................................165
9.1.4.2 Smoking....................................................................................................................................................166
9.1.4.3 Physiological Functions..........................................................................................................................168
9.1.4.4 Quality of Life..........................................................................................................................................168
9.1.5 Epidemiological Indicators of Geriatric Health..................................................................................................169
9.1.5.1 Activities of Daily Living.......................................................................................................................169
9.1.5.2 Mental Health of the Elderly.................................................................................................................169
9.2 Reference Values..................................................................................................................................................................169
9.2.1 Gaussian and Other Distributions.......................................................................................................................169
9.2.1.1 Properties of a Gaussian Distribution..................................................................................................170
9.2.1.2 Other Distributions.................................................................................................................................171
xvi Contents

9.2.1.3 Checking Gaussianity: Simple but Approximate Methods..............................................................172


9.2.2 Reference or Normal Values.................................................................................................................................. 174
9.2.2.1 Implications of Normal Values.............................................................................................................. 174
9.2.3 Normal Range.........................................................................................................................................................175
9.2.3.1 Disease Threshold...................................................................................................................................175
9.2.3.2 Clinical Threshold...................................................................................................................................175
9.2.3.3 Statistical Threshold...............................................................................................................................176
9.3 Measurement of Uncertainty: Probability........................................................................................................................177
9.3.1 Elementary Laws of Probability...........................................................................................................................177
9.3.1.1 Law of Multiplication.............................................................................................................................178
9.3.1.2 Law of Addition.......................................................................................................................................178
9.3.2 Probability in Clinical Assessments....................................................................................................................179
9.3.2.1 Probabilities in Diagnosis......................................................................................................................179
9.3.2.2 Forwarding Diagnosis............................................................................................................................180
9.3.2.3 Assessment of Prognosis........................................................................................................................180
9.3.2.4 Choice of Treatment................................................................................................................................181
9.3.3 Further on Diagnosis: Bayes’ Rule.......................................................................................................................181
9.3.3.1 Bayes’ Rule...............................................................................................................................................181
9.3.3.2 Extension of Bayes’ Rule.........................................................................................................................182
9.4 Validity of Medical Tests.....................................................................................................................................................183
9.4.1 Sensitivity and Specificity.....................................................................................................................................184
9.4.1.1 Features of Sensitivity and Specificity.................................................................................................185
9.4.1.2 Likelihood Ratio......................................................................................................................................186
9.4.2 Predictivities............................................................................................................................................................186
9.4.2.1 Positive and Negative Predictivity.......................................................................................................186
9.4.2.2 Predictivity and Prevalence...................................................................................................................187
9.4.2.3 Meaning of Prevalence for Predictivity...............................................................................................188
9.4.2.4 Features of Positive and Negative Predictivities................................................................................189
9.4.3 Combination of Tests..............................................................................................................................................190
9.4.3.1 Tests in Series...........................................................................................................................................190
9.4.3.2 Tests in Parallel........................................................................................................................................190
9.4.4 Gains from a Test....................................................................................................................................................191
9.4.4.1 When Can a Test Be Avoided?...............................................................................................................192
9.5 Search for the Best Threshold of a Continuous Test: ROC Curve.................................................................................192
9.5.1 Sensitivity–Specificity-Based ROC Curve...........................................................................................................192
9.5.1.1 Methods to Find the Optimal Threshold Point..................................................................................194
9.5.1.2 Area under the ROC Curve...................................................................................................................195
9.5.2 Predictivity-Based ROC Curve.............................................................................................................................197
References........................................................................................................................................................................................198
Exercises...........................................................................................................................................................................................199

10. Clinimetrics and Evidence-Based Medicine............................................................................................................................203


10.1 Indicators, Indices, and Scores...........................................................................................................................................203
10.1.1 Indicators..................................................................................................................................................................203
10.1.1.1 Merits and Demerits of Indicators........................................................................................................203
10.1.1.2 Choice of Indicators................................................................................................................................204
10.1.2 Indices.......................................................................................................................................................................204
10.1.3 Scores........................................................................................................................................................................204
10.1.3.1 Scoring System for Diagnosis................................................................................................................205
10.1.3.2 Scoring for Gradation of Severity.........................................................................................................206
10.1.3.3 APACHE Scores.......................................................................................................................................207
10.2 Clinimetrics..........................................................................................................................................................................208
10.2.1 Method of Scoring..................................................................................................................................................208
10.2.1.1 Method of Scoring for Graded Characteristics...................................................................................208
10.2.1.2 Method of Scoring for Diagnosis..........................................................................................................209
Contents xvii

10.2.1.3 Regression Method for Scoring.............................................................................................................209


10.2.2 Validity and Reliability of a Scoring System......................................................................................................210
10.2.2.1 Validity of a Scoring System..................................................................................................................210
10.2.2.2 Reliability of a Scoring System..............................................................................................................211
10.3 Evidence-Based Medicine...................................................................................................................................................212
10.3.1 Decision Analysis...................................................................................................................................................212
10.3.1.1 Decision Tree............................................................................................................................................212
10.3.2 Other Statistical Tools for Evidence-Based Medicine........................................................................................213
10.3.2.1 Etiology Diagram....................................................................................................................................213
10.3.2.2 Expert System.......................................................................................................................................... 214
References........................................................................................................................................................................................215
Exercises...........................................................................................................................................................................................216

11. Measurement of Community Health........................................................................................................................................219


11.1 Measures of Fertility and Medical Demography............................................................................................................219
11.1.1 Indicators of Fertility..............................................................................................................................................219
11.1.2 Medical Demography.............................................................................................................................................221
11.1.2.1 Population Pyramid................................................................................................................................221
11.1.2.2 Demographic Cycle.................................................................................................................................222
11.1.2.3 Other Demographic Indicators.............................................................................................................223
11.1.2.4 Stable and Stationary Population..........................................................................................................223
11.1.2.5 Sex Ratio...................................................................................................................................................223
11.2 Indicators of Mortality........................................................................................................................................................224
11.2.1 Crude and Standardized Death Rates.................................................................................................................224
11.2.1.1 Crude Death Rate....................................................................................................................................224
11.2.1.2 Age-Specific Death Rate.........................................................................................................................224
11.2.1.3 Standardized Death Rate.......................................................................................................................224
11.2.1.4 Comparative Mortality Ratio.................................................................................................................227
11.2.2 Specific Mortality Rates.........................................................................................................................................228
11.2.2.1 Fetal Deaths and Mortality in Children..............................................................................................228
11.2.2.2 Maternal Mortality..................................................................................................................................230
11.2.2.3 Adult Mortality........................................................................................................................................230
11.2.2.4 Other Measures of Mortality.................................................................................................................231
11.2.3 Death Spectrum......................................................................................................................................................231
11.3 Measures of Morbidity........................................................................................................................................................232
11.3.1 Prevalence and Incidence......................................................................................................................................232
11.3.1.1 Point Prevalence......................................................................................................................................232
11.3.1.2 Period Prevalence....................................................................................................................................233
11.3.1.3 Prevalence Rate Ratio.............................................................................................................................233
11.3.1.4 Incidence...................................................................................................................................................233
11.3.1.5 Concept of Person-Time..........................................................................................................................234
11.3.1.6 Capture–Recapture Methodology........................................................................................................234
11.3.2 Duration of Morbidity............................................................................................................................................235
11.3.2.1 Prevalence in Relation to Duration of Morbidity...............................................................................236
11.3.2.2 Incidence from Prevalence.....................................................................................................................236
11.3.2.3 Epidemiologically Consistent Estimates..............................................................................................237
11.3.3 Morbidity Measures for Acute Conditions.........................................................................................................237
11.3.3.1 Attack Rates.............................................................................................................................................238
11.3.3.2 Disease Spectrum....................................................................................................................................238
11.4 Indicators of Social and Mental Health............................................................................................................................240
11.4.1 Indicators of Social Health....................................................................................................................................240
11.4.1.1 Education..................................................................................................................................................240
11.4.1.2 Income.......................................................................................................................................................241
11.4.1.3 Occupation...............................................................................................................................................241
11.4.1.4 Socioeconomic Status.............................................................................................................................241
xviii Contents

11.4.1.5 Dependency Ratio...................................................................................................................................242


11.4.1.6 Dietary Assessment................................................................................................................................242
11.4.1.7 Health Inequality....................................................................................................................................242
11.4.2 Indicators of Health Resources.............................................................................................................................243
11.4.2.1 Health Infrastructure.............................................................................................................................243
11.4.2.2 Health Expenditure................................................................................................................................244
11.4.3 Indicators of Lack of Mental Health.....................................................................................................................245
11.4.3.1 Smoking and Other Addictions............................................................................................................245
11.4.3.2 Divorces....................................................................................................................................................245
11.4.3.3 Vehicular Accidents and Crimes..........................................................................................................245
11.4.3.4 Other Measures of Lack of Mental Health..........................................................................................245
11.5 Composite Indices of Health..............................................................................................................................................246
11.5.1 Indices of Status of Comprehensive Health........................................................................................................246
11.5.1.1 Human Development Index..................................................................................................................246
11.5.1.2 Physical Quality of Life Index...............................................................................................................247
11.5.1.3 Index of Happiness.................................................................................................................................247
11.5.2 Indices of (Physical) Health Gap...........................................................................................................................248
11.5.2.1 DALYs Lost...............................................................................................................................................248
11.5.2.2 Human Poverty Index............................................................................................................................249
11.5.2.3 Index of Need for Health Resources.....................................................................................................249
References........................................................................................................................................................................................249
Exercises...........................................................................................................................................................................................250

12. Confidence Intervals, Principles of Tests of Significance, and Sample Size.....................................................................255


12.1 Sampling Distributions.......................................................................................................................................................255
12.1.1 Basic Concepts.........................................................................................................................................................255
12.1.1.1 Sampling Error........................................................................................................................................256
12.1.1.2 Point Estimate..........................................................................................................................................256
12.1.1.3 Standard Error of p and x......................................................................................................................256
12.1.2 Sampling Distribution of p and x.........................................................................................................................258
12.1.2.1 Gaussian Conditions...............................................................................................................................258
12.1.3 Obtaining Probabilities from a Gaussian Distribution.....................................................................................259
12.1.3.1 Gaussian Probability...............................................................................................................................259
12.1.3.2 Continuity Correction............................................................................................................................261
12.1.3.3 Probabilities Relating to the Mean and the Proportion.....................................................................261
12.1.4 Case of σ Not Known (t-Distribution)..................................................................................................................262
12.2 Confidence Intervals............................................................................................................................................................262
12.2.1 Confidence Interval for π, μ, and Median: Gaussian Conditions.....................................................................263
12.2.1.1 Confidence Interval for Proportion π (Large n)..................................................................................263
12.2.1.2 Lower and Upper Bounds for π (Large n)............................................................................................265
12.2.1.3 Confidence Interval for Mean μ (Large n)............................................................................................265
12.2.1.4 Confidence Bounds for Mean μ (Large n)............................................................................................267
12.2.1.5 CI for Median (Gaussian Distribution)................................................................................................268
12.2.2 Confidence Interval for Differences (Large n)....................................................................................................269
12.2.2.1 CI for the Difference in Two Independent Samples...........................................................................269
12.2.2.2 Paired Samples........................................................................................................................................270
12.2.3 Confidence Interval for π, μ, and Median: Non-Gaussian Conditions............................................................271
12.2.3.1 Confidence Interval for π (Small n).......................................................................................................272
12.2.3.2 Confidence Bound for π When the Success or Failure Rate in the Sample Is 0%..........................273
12.2.3.3 Confidence Interval for Median: Non-Gaussian Conditions............................................................274
12.3 P-Values and Statistical Significance.................................................................................................................................276
12.3.1 What Is Statistical Significance?...........................................................................................................................276
12.3.1.1 Court Judgment.......................................................................................................................................277
12.3.1.2 Errors in Diagnosis.................................................................................................................................277
12.3.1.3 Null Hypothesis......................................................................................................................................277
Contents xix

12.3.1.4 Philosophical Basis of Statistical Tests.................................................................................................278


12.3.1.5 Alternative Hypothesis..........................................................................................................................278
12.3.1.6 One-Sided Alternatives: Which Tail Is Wagging?..............................................................................278
12.3.2 Errors, P-Values, and Power..................................................................................................................................279
12.3.2.1 Type I Error..............................................................................................................................................279
12.3.2.2 Type II Error.............................................................................................................................................280
12.3.2.3 Power.........................................................................................................................................................280
12.3.3 General Procedure to Obtain the P-Value...........................................................................................................281
12.3.3.1 Steps to Obtain a P-Value.......................................................................................................................281
12.3.3.2 Subtleties of Statistical Significance.....................................................................................................283
12.4 Assessing Gaussian Pattern................................................................................................................................................284
12.4.1 Approximate Methods for Assessing Gaussianity............................................................................................284
12.4.2 Significance Tests for Assessing Gaussianity.....................................................................................................285
12.4.2.1 Statistical Tests.........................................................................................................................................285
12.4.2.2 Transformations to Achieve Gaussianity............................................................................................285
12.5 Initial Debate on Statistical Significance..........................................................................................................................286
12.5.1 Confidence Interval versus Test of H0..................................................................................................................286
12.5.1.1 Equivalence of CI with Test of H0.........................................................................................................286
12.5.1.2 Valid Application of Test of Hypothesis..............................................................................................287
12.5.2 Medical Significance versus Statistical Significance..........................................................................................287
12.6 Sample Size Determination in Some Cases......................................................................................................................289
12.6.1 Sample Size Required in Estimation Setup........................................................................................................289
12.6.1.1 General Considerations for Sample Size in Estimation Setup..........................................................289
12.6.1.2 General Procedure for Determining the Sample Size for Estimation.............................................291
12.6.1.3 Formulas for Sample Size Calculation for Estimation in Simple Situations..................................292
12.6.2 Sample Size for Testing a Hypothesis with Specified Power...........................................................................294
12.6.2.1 General Considerations for Sample Size in a Testing of Hypothesis Setup...................................294
12.6.2.2 Power Calculations.................................................................................................................................295
12.6.2.3 Sample Size Formulas for Test of Hypothesis in Simple Situations................................................295
12.6.2.4 Sample Size in Some Other Popular Setups........................................................................................298
12.6.2.5 Nomograms and Tables of Sample Size...............................................................................................299
12.6.2.6 Thumb Rules............................................................................................................................................299
12.6.2.7 Power Analysis....................................................................................................................................... 300
12.6.3 Sample Size in Adaptive Clinical Trials............................................................................................................. 300
12.6.3.1 Stopping Rules in Case of Early Evidence of Success or Failure: Lan–deMets Procedure...........301
12.6.3.2 Sample Size Reestimation in Adaptive Designs.................................................................................302
References........................................................................................................................................................................................303
Exercises...........................................................................................................................................................................................304

13. Inference from Proportions.........................................................................................................................................................307


13.1 One Qualitative Variable.....................................................................................................................................................307
13.1.1 Dichotomous Categories: Binomial Distribution...............................................................................................307
13.1.1.1 Binomial Distribution.............................................................................................................................308
13.1.1.2 Large n: Gaussian Approximation to Binomial..................................................................................309
13.1.1.3 Z-Test for Proportion in One Group.....................................................................................................310
13.1.2 Poisson Distribution...............................................................................................................................................310
13.1.3 Polytomous Categories (Large n): Goodness-of-Fit Test.................................................................................... 311
13.1.3.1 Chi-Square and Its Explanation............................................................................................................312
13.1.3.2 Degrees of Freedom................................................................................................................................313
13.1.3.3 Cautions in Using Chi-Square...............................................................................................................313
13.1.3.4 Further Analysis: Partitioning of Tables.............................................................................................. 314
13.1.4 Goodness of Fit to Assess Gaussianity................................................................................................................315
13.1.5 Polytomous Categories (Small n): Exact Multinomial Test............................................................................... 316
13.1.5.1 Goodness of Fit in Small Samples......................................................................................................... 316
13.1.5.2 Data with Rare Outcomes: Negative Binomial Distribution............................................................317
xx Contents

13.2 Proportions in 2×2 Tables....................................................................................................................................................318


13.2.1 Structure of 2×2 Table in Different Types of Study............................................................................................318
13.2.1.1 Structure in Prospective Study.............................................................................................................318
13.2.1.2 Structure in Retrospective Study..........................................................................................................318
13.2.1.3 Structure in Cross-Sectional Study......................................................................................................319
13.2.2 Two Independent Samples (Large n): Chi-Square Test and Proportion Test in a 2×2 Table........................319
13.2.2.1 Chi-Square Test for a 2×2 Table.............................................................................................................319
13.2.2.2 Yates’ Correction for Continuity...........................................................................................................320
13.2.2.3 Z-Test for Difference in Proportions in Two Independent Groups..................................................320
13.2.2.4 Detecting a Medically Important Difference in Proportions...........................................................321
13.2.2.5 Crossover Design with Binary Response (Large n)...........................................................................322
13.2.3 Equivalence Tests....................................................................................................................................................323
13.2.3.1 Superiority, Equivalence, and Noninferiority.....................................................................................323
13.2.3.2 Testing Equivalence................................................................................................................................324
13.2.3.3 Determining Noninferiority Margin...................................................................................................326
13.2.4 Two Independent Samples (Small n): Fisher Exact Test.....................................................................................326
13.2.4.1 Fisher Exact Test......................................................................................................................................326
13.2.4.2 Crossover Design (Small n)....................................................................................................................327
13.2.5 Proportions in Matched Pairs: McNemar Test (Large n) and Exact Test (Small n).......................................328
13.2.5.1 Large n: McNemar Test..........................................................................................................................328
13.2.5.2 Small n: Exact Test (Matched Pairs)......................................................................................................329
13.2.5.3 Comparison of Two Tests for Sensitivity and Specificity: Paired Setup.........................................330
13.3 Analysis of R×C Tables (Large n).......................................................................................................................................331
13.3.1 One Dichotomous and the Other Polytomous Variable (2×C Table)...............................................................331
13.3.1.1 Test Criterion for Association in R×C Tables.......................................................................................332
13.3.1.2 Trend in Proportions in Ordinal Categories.......................................................................................332
13.3.1.3 Dichotomy in Repeated Measures: Cochran Q-Test (Large n)..........................................................334
13.3.2 Two Polytomous Variables.....................................................................................................................................335
13.3.2.1 Chi-Square Test for Large n...................................................................................................................336
13.3.2.2 Matched Pairs: I×I Table and McNemar–Bowker Test.......................................................................337
13.4 Three-Way Tables.................................................................................................................................................................337
13.4.1 Assessment of Association in Three-Way Tables...............................................................................................338
13.4.2 Log-Linear Models..................................................................................................................................................340
13.4.2.1 Log-Linear Model for Two-Way Tables................................................................................................341
13.4.2.2 Log-Linear Model for Three-Way Tables.............................................................................................341
References........................................................................................................................................................................................343
Exercises...........................................................................................................................................................................................343

14. Relative Risk and Odds Ratio.....................................................................................................................................................347


14.1 Relative and Attributable Risks (Large n)........................................................................................................................347
14.1.1 Risk, Hazard, and Odds.........................................................................................................................................347
14.1.1.1 Risk............................................................................................................................................................347
14.1.1.2 Hazard Rate.............................................................................................................................................348
14.1.1.3 Odds..........................................................................................................................................................348
14.1.1.4 Ratios of Risks and Odds.......................................................................................................................348
14.1.2 Relative Risk............................................................................................................................................................348
14.1.2.1 RR in Independent Samples..................................................................................................................348
14.1.2.2 Confidence Interval for RR (Independent Samples)..........................................................................351
14.1.2.3 Test of Hypothesis on RR (Independent Samples).............................................................................352
14.1.2.4 RR in the Case of Matched Pairs...........................................................................................................353
14.1.3 Attributable Risk.....................................................................................................................................................353
14.1.3.1 AR in Independent Samples..................................................................................................................353
14.1.3.2 AR in Matched Pairs...............................................................................................................................354
14.1.3.3 Number Needed to Treat.......................................................................................................................355
Contents xxi

14.1.3.4 Risk Reduction.........................................................................................................................................356


14.1.3.5 Population Attributable Risk.................................................................................................................357
14.2 Odds Ratio.............................................................................................................................................................................357
14.2.1 OR in Two Independent Samples.........................................................................................................................358
14.2.1.1 Interpretation of OR................................................................................................................................358
14.2.1.2 CI for OR (Independent Samples).........................................................................................................360
14.2.1.3 Test of Hypothesis on OR (Independent Samples).............................................................................360
14.2.2 OR in Matched Pairs...............................................................................................................................................361
14.2.2.1 Confidence Interval for OR (Matched Pairs).......................................................................................362
14.2.2.2 Test of Hypothesis on OR (Matched Pairs)..........................................................................................362
14.2.2.3 Multiple Controls....................................................................................................................................363
14.3 Stratified Analysis, Sample Size, and Meta-Analysis.....................................................................................................364
14.3.1 Mantel–Haenszel Procedure.................................................................................................................................364
14.3.1.1 Pooled Relative Risk................................................................................................................................364
14.3.1.2 Pooled Odds Ratio and Chi-Square......................................................................................................365
14.3.2 Sample Size Requirement for Statistical Inference on RR and OR..................................................................366
14.3.3 Meta-Analysis..........................................................................................................................................................370
14.3.3.1 Forest Plot.................................................................................................................................................370
14.3.3.2 Validity of Meta-Analysis......................................................................................................................371
References........................................................................................................................................................................................372
Exercises...........................................................................................................................................................................................372

15. Inference from Means..................................................................................................................................................................377


15.1 Comparison of Means in One and Two Groups (Gaussian Conditions): Student t-Test............................................378
15.1.1 Comparison with a Prespecified Mean...............................................................................................................378
15.1.1.1 Student t-Test for One Sample...............................................................................................................378
15.1.2 Difference in Means in Two Samples...................................................................................................................379
15.1.2.1 Paired Samples Setup.............................................................................................................................380
15.1.2.2 Unpaired (Independent) Samples Setup..............................................................................................380
15.1.2.3 Some Features of Student t....................................................................................................................382
15.1.2.4 Effect of Unequal n..................................................................................................................................383
15.1.2.5 Difference-in-Differences Approach....................................................................................................383
15.1.3 Analysis of Crossover Designs.............................................................................................................................383
15.1.3.1 Test for Group Effect...............................................................................................................................384
15.1.3.2 Test for Carryover Effect........................................................................................................................385
15.1.3.3 Test for Treatment Effect........................................................................................................................385
15.1.4 Analysis of Data of Up-and-Down Trials............................................................................................................386
15.2 Comparison of Means in 3 or More Groups (Gaussian Conditions): ANOVA F-Test................................................387
15.2.1 One-Way ANOVA...................................................................................................................................................387
15.2.1.1 Procedure to Test H0...............................................................................................................................388
15.2.1.2 Checking the Validity of the Assumptions of ANOVA.....................................................................391
15.2.2 Two-Way ANOVA...................................................................................................................................................392
15.2.2.1 Two-Factor Design..................................................................................................................................392
15.2.2.2 Hypotheses and Their Test in Two-Way ANOVA..............................................................................393
15.2.2.3 Main Effect and Interaction (Effect).....................................................................................................395
15.2.2.4 Type I, Type II, and Type III Sums of Squares....................................................................................396
15.2.3 Repeated Measures.................................................................................................................................................397
15.2.3.1 Random Effects versus Fixed Effects and Mixed Models.................................................................397
15.2.3.2 Sphericity and Huynh–Feldt Correction.............................................................................................397
15.2.4 Multiple Comparisons: Bonferroni, Tukey, and Dunnett Tests.......................................................................398
15.2.4.1 Bonferroni Procedure.............................................................................................................................399
15.2.4.2 Tukey Test.................................................................................................................................................399
15.2.4.3 Dunnett Test............................................................................................................................................ 400
15.2.4.4 Intricacies of Multiple Comparisons................................................................................................... 400
xxii Contents

15.3 Non-Gaussian Conditions: Nonparametric Tests for Location.....................................................................................401


15.3.1 Comparison of Two Groups: Wilcoxon Tests......................................................................................................401
15.3.1.1 Case I: Paired Data—Sign Test and Wilcoxon Signed-Rank Test.....................................................401
15.3.1.2 Case II: Independent Samples—Wilcoxon Rank-Sum Test...............................................................404
15.3.2 Comparison of Three or More Groups: Kruskal–Wallis Test...........................................................................406
15.3.3 Two-Way Layout with n = 1: Friedman Test for Repeated Samples................................................................407
15.4 When Significant Is Not Significant..................................................................................................................................410
15.4.1 Nature of Statistical Significance..........................................................................................................................410
15.4.2 Testing for the Presence of a Medically Important Difference in Means.......................................................413
15.4.2.1 Detecting Specified Difference in Mean.............................................................................................. 414
15.4.2.2 Equivalence Tests for Means.................................................................................................................415
15.4.3 Power and Level of Significance...........................................................................................................................415
15.4.3.1 Further Explanation of Statistical Power.............................................................................................415
15.4.3.2 Balancing Type I and Type II Error......................................................................................................417
References........................................................................................................................................................................................418
Exercises...........................................................................................................................................................................................418

16. Relationships: Quantitative Outcome.......................................................................................................................................423


16.1 Some General Features of a Regression Setup.................................................................................................................424
16.1.1 Dependent and Independent Variables...............................................................................................................425
16.1.1.1 Simple, Multiple, and Multivariate Regressions.................................................................................425
16.1.2 Linear, Curvilinear, and Nonlinear Regressions...............................................................................................425
16.1.2.1 Linear Regression....................................................................................................................................425
16.1.2.2 Curvilinear Regression...........................................................................................................................426
16.1.2.3 Nonlinear Regressions...........................................................................................................................427
16.1.2.4 Regression through Origin....................................................................................................................428
16.1.3 Concept of Residuals..............................................................................................................................................428
16.1.4 General Method of Fitting a Regression..............................................................................................................429
16.1.5 Selection of Regressors...........................................................................................................................................430
16.1.5.1 Multicollinearity......................................................................................................................................431
16.1.5.2 Statistical Significance: Stepwise Procedures.....................................................................................431
16.1.5.3 Other Considerations..............................................................................................................................432
16.2 Linear Regression Models..................................................................................................................................................432
16.2.1 Simple Linear Regression......................................................................................................................................433
16.2.1.1 Meaning of Intercept and Slope in Simple Linear Regression.........................................................434
16.2.1.2 Estimation of Parameters of Simple Linear Regression....................................................................434
16.2.1.3 Confidence Intervals for the Parameters of Simple Linear Regression...........................................435
16.2.1.4 Tests of Hypothesis for the Parameters of Simple Linear Regression.............................................436
16.2.1.5 Confidence Band for Simple Linear Regression.................................................................................437
16.2.2 Multiple Linear Regression...................................................................................................................................438
16.2.2.1 Elements of Multiple Linear Regression..............................................................................................438
16.2.2.2 Understanding Multiple Linear Regression........................................................................................439
16.2.2.3 CI and Tests in Multiple Linear Regression....................................................................................... 440
16.3 Adequacy of a Regression.................................................................................................................................................. 440
16.3.1 Goodness of Fit and η2.......................................................................................................................................... 440
16.3.2 Multiple Correlation in Multiple Linear Regression........................................................................................ 440
16.3.3 Statistical Significance of Individual Regression Coefficients.........................................................................441
16.3.4 Validity of Assumptions....................................................................................................................................... 442
16.3.5 Choice of the Form of Regression........................................................................................................................ 443
16.3.6 Outliers and Missing Values................................................................................................................................ 446
16.4 Some Issues in Linear Regression.................................................................................................................................... 446
16.4.1 Implications of Regression....................................................................................................................................447
16.4.1.1 Standardized Coefficients......................................................................................................................447
16.4.1.2 Other Implications of Regression Models...........................................................................................447
Contents xxiii

16.4.1.3 Equality of Two Regression Lines........................................................................................................ 448


16.4.1.4 Difference-in-Differences Approach with Regression...................................................................... 448
16.4.2 Some Variations of Regression..............................................................................................................................449
16.4.2.1 Ridge Regression.....................................................................................................................................449
16.4.2.2 Multilevel Regression.............................................................................................................................449
16.4.2.3 Regression Splines..................................................................................................................................450
16.4.2.4 Analysis of Covariance...........................................................................................................................451
16.4.2.5 Some Generalizations.............................................................................................................................452
16.5 Measuring the Strength of Quantitative Relationship...................................................................................................452
16.5.1 Product–Moment and Related Correlations.......................................................................................................452
16.5.1.1 Product–Moment Correlation................................................................................................................452
16.5.1.2 Statistical Significance of r.....................................................................................................................455
16.5.1.3 Comparison of Correlations in Two Independent Samples..............................................................456
16.5.1.4 Serial Correlation....................................................................................................................................456
16.5.1.5 Partial Correlation...................................................................................................................................456
16.5.2 Rank Correlation.....................................................................................................................................................457
16.5.2.1 Spearman Rho.........................................................................................................................................457
16.5.3 Intraclass Correlation.............................................................................................................................................458
16.5.3.1 Computation of Intraclass Correlation.................................................................................................459
16.5.3.2 ANOVA Formulation and Testing the Statistical Significance of ICC.............................................459
16.6 Assessment of Quantitative Agreement...........................................................................................................................460
16.6.1 Agreement in Quantitative Measurements........................................................................................................460
16.6.1.1 Statistical Formulation of the Problem of Agreement.......................................................................460
16.6.1.2 Limits of Disagreement Approach.......................................................................................................461
16.6.1.3 Intraclass Correlation as a Measure of Agreement............................................................................462
16.6.1.4 Relative Merits of the Two Methods.....................................................................................................462
16.6.2 Alternative Methods for Assessment of Agreement.........................................................................................463
16.6.2.1 Alternative Simple Approach to Agreement Assessment.................................................................463
16.6.2.2 Agreement Assessment for Different Measurements........................................................................464
References........................................................................................................................................................................................464
Exercises...........................................................................................................................................................................................465

17. Relationships: Qualitative Dependent......................................................................................................................................469


17.1 Binary Dependent: Logistic Regression (Large n)...........................................................................................................469
17.1.1 Meaning of a Logistic Model................................................................................................................................470
17.1.1.1 Logit and Logistic Coefficients..............................................................................................................470
17.1.1.2 Logistic versus Quantitative Regression.............................................................................................470
17.1.1.3 Etiological Specification of a Logistic Model......................................................................................472
17.1.2 Assessing the Overall Adequacy of a Logistic Regression...............................................................................472
17.1.2.1 Log-Likelihood........................................................................................................................................472
17.1.2.2 Classification Accuracy..........................................................................................................................474
17.1.2.3 Hosmer–Lemeshow Test........................................................................................................................474
17.1.2.4 Other Methods of Assessing the Adequacy of a Logistic Regression.............................................475
17.2 Inference from Logistic Coefficients.................................................................................................................................477
17.2.1 Interpretation of the Logistic Coefficients...........................................................................................................477
17.2.1.1 Dichotomous Regressors........................................................................................................................477
17.2.1.2 Polytomous Regressors..........................................................................................................................478
17.2.1.3 Continuous Regressors and Linearity.................................................................................................479
17.2.2 Confidence Interval and Test of Hypothesis on Logistic Coefficients............................................................480
17.3 Issues in Logistic Regression..............................................................................................................................................482
17.3.1 Conditional Logistic for Matched Data...............................................................................................................482
17.3.2 Polytomous Dependent..........................................................................................................................................483
17.3.2.1 Nominal Categories of the Dependent: Multinomial Logistic.........................................................483
17.3.2.2 Ordinal Categories of the Dependent Variable...................................................................................483
xxiv Contents

17.4 Some Models for Qualitative Data and Generalizations................................................................................................484


17.4.1 Cox Regression for Hazards..................................................................................................................................484
17.4.2 Classification and Regression Tree.......................................................................................................................485
17.4.3 Further Generalizations.........................................................................................................................................486
17.4.3.1 Generalized Linear Models...................................................................................................................486
17.4.3.2 Generalized Estimating Equations.......................................................................................................486
17.4.4 Propensity Score Approach...................................................................................................................................487
17.5 Strength of Relationship in Qualitative Variables...........................................................................................................488
17.5.1 Both Variables Qualitative.....................................................................................................................................488
17.5.1.1 Dichotomous Categories........................................................................................................................488
17.5.1.2 Polytomous Categories: Nominal.........................................................................................................490
17.5.1.3 Proportional Reduction in Error (PRE)................................................................................................491
17.5.1.4 Polytomous Categories: Ordinal Association.....................................................................................492
17.5.2 One Qualitative and the Other Quantitative Variable......................................................................................494
17.5.2.1 Coefficient of Determination as a Measure of the Degree of Relationship....................................494
17.5.2.2 Biserial Correlation.................................................................................................................................495
17.5.3 Agreement in Qualitative Measurements (Matched Pairs)..............................................................................495
17.5.3.1 Meaning of Qualitative Agreement......................................................................................................495
17.5.3.2 Cohen Kappa............................................................................................................................................496
17.5.3.3 Agreement Charts...................................................................................................................................497
References........................................................................................................................................................................................498
Exercises...........................................................................................................................................................................................499

18. Survival Analysis..........................................................................................................................................................................503


18.1 Life Expectancy....................................................................................................................................................................503
18.1.1 Life Table..................................................................................................................................................................504
18.1.2 Other Forms of Life Expectancy...........................................................................................................................507
18.1.2.1 Potential Years of Life Lost....................................................................................................................507
18.1.2.2 Healthy Life Expectancy........................................................................................................................507
18.1.2.3 Application to Other Setups..................................................................................................................507
18.2 Analysis of Survival Data...................................................................................................................................................508
18.2.1 Nature of Survival Data.........................................................................................................................................508
18.2.1.1 Types of Censoring.................................................................................................................................508
18.2.1.2 Collection of Survival Time Data..........................................................................................................509
18.2.1.3 Statistical Measures of Survival............................................................................................................510
18.2.2 Survival Observed in Time Intervals: Life Table Method................................................................................510
18.2.2.1 Life Table Method...................................................................................................................................510
18.2.2.2 Survival Function....................................................................................................................................511
18.2.3 Continuous Observation of Survival Time: Kaplan–Meier Method...............................................................513
18.2.3.1 Kaplan–Meier Method............................................................................................................................513
18.2.3.2 Using the Survival Curve for Some Estimations................................................................................515
18.2.3.3 Standard Error of Survival Rate (K–M Method).................................................................................515
18.2.3.4 Hazard Function.....................................................................................................................................516
18.3 Issues in Survival Analysis.................................................................................................................................................517
18.3.1 Comparison of Survival in Two Groups..............................................................................................................517
18.3.1.1 Comparing Survival Rates.....................................................................................................................518
18.3.1.2 Comparing Survival Experience: Log-Rank Test...............................................................................519
18.3.2 Factors Affecting the Chance of Survival: Cox Model......................................................................................521
18.3.2.1 Parametric Models..................................................................................................................................521
18.3.2.2 Cox Model for Survival..........................................................................................................................522
18.3.2.3 Proportional Hazards.............................................................................................................................522
18.3.3 Sample Size for Hazard Ratios and Survival Studies.......................................................................................524
References........................................................................................................................................................................................525
Exercises...........................................................................................................................................................................................526
Contents xxv

19. Simultaneous Consideration of Several Variables.................................................................................................................529


19.1 Scope of Multivariate Methods..........................................................................................................................................529
19.1.1 Essentials of a Multivariate Setup........................................................................................................................530
19.1.2 Statistical Limitation on the Number of Variables.............................................................................................530
19.2 Dependent and Independent Sets of Variables................................................................................................................531
19.2.1 Dependents and Independents Both Quantitative............................................................................................531
19.2.1.1 Canonical Correlation.............................................................................................................................531
19.2.1.2 Multivariate Multiple Regression.........................................................................................................532
19.2.1.3 Path Analysis...........................................................................................................................................535
19.2.2 Quantitative Dependents and Qualitative Independents: Multivariate Analysis of Variance...................536
19.2.2.1 Regular MANOVA..................................................................................................................................537
19.2.2.2 MANOVA for Repeated Measures.......................................................................................................539
19.2.3 Classification of Subjects into Known Groups: Discriminant Analysis.........................................................539
19.2.3.1 Discriminant Functions.........................................................................................................................539
19.2.3.2 Classification Rule...................................................................................................................................540
19.2.3.3 Classification Accuracy..........................................................................................................................540
19.3 Identification of Structure in the Observations...............................................................................................................543
19.3.1 Identification of Clusters of Subjects: Cluster Analysis.....................................................................................543
19.3.1.1 Measures of Similarity...........................................................................................................................543
19.3.1.2 Hierarchical Agglomerative Algorithm.............................................................................................. 544
19.3.1.3 Deciding on the Number of Natural Clusters....................................................................................545
19.3.2 Identification of Unobservable Underlying Factors: Factor Analysis..............................................................546
19.3.2.1 Factor Analysis........................................................................................................................................547
19.3.2.2 Steps for Factor Analysis........................................................................................................................548
19.3.2.3 Features of a Successful Factor Analysis.............................................................................................549
19.3.2.4 Factor Scores.............................................................................................................................................550
References........................................................................................................................................................................................550
Exercises...........................................................................................................................................................................................551

20. Quality Considerations................................................................................................................................................................555


20.1 Statistical Quality Control in Medical Care.....................................................................................................................555
20.1.1 Statistical Control of Medical Care Errors..........................................................................................................556
20.1.1.1 Adverse Patient Outcomes.....................................................................................................................556
20.1.1.2 Monitoring Fatality.................................................................................................................................557
20.1.1.3 Limits of Tolerance..................................................................................................................................557
20.1.2 Quality of Lots.........................................................................................................................................................558
20.1.2.1 Lot Quality Method................................................................................................................................558
20.1.2.2 LQAS in Health Assessment..................................................................................................................558
20.1.3 Quality Control in a Medical Laboratory............................................................................................................559
20.1.3.1 Control Chart...........................................................................................................................................559
20.1.3.2 Cusum Chart............................................................................................................................................560
20.1.3.3 Other Errors in a Medical Laboratory..................................................................................................561
20.1.3.4 Six Sigma Methodology.........................................................................................................................561
20.1.3.5 Nonstatistical Issues...............................................................................................................................561
20.2 Quality of Measurement Instruments..............................................................................................................................562
20.2.1 Validity of Instruments..........................................................................................................................................562
20.2.1.1 Types of Validity......................................................................................................................................562
20.2.2 Reliability of Instruments......................................................................................................................................563
20.2.2.1 Internal Consistency...............................................................................................................................563
20.2.2.2 Cronbach Alpha.......................................................................................................................................564
20.2.2.3 Test–Retest Reliability.............................................................................................................................565
20.3 Quality of Statistical Models: Robustness........................................................................................................................566
20.3.1 Limitations of Statistical Models..........................................................................................................................566
xxvi Contents

20.3.2 Validation of the Models........................................................................................................................................567


20.3.2.1 Internal Validation..................................................................................................................................567
20.3.2.2 External Validation.................................................................................................................................568
20.3.3 Sensitivity Analysis and Uncertainty Analysis.................................................................................................568
20.3.3.1 Sensitivity Analysis................................................................................................................................568
20.3.3.2 Uncertainty Analysis..............................................................................................................................569
20.3.4 Resampling..............................................................................................................................................................570
20.3.4.1 Bootstrapping..........................................................................................................................................570
20.3.4.2 Jackknife Resampling.............................................................................................................................571
20.3.4.3 Optimistic Index......................................................................................................................................571
20.4 Quality of Data.....................................................................................................................................................................572
20.4.1 Errors in Measurement..........................................................................................................................................572
20.4.1.1 Lack of Standardization in Definitions................................................................................................572
20.4.1.2 Lack of Care in Obtaining or Recording Information.......................................................................572
20.4.1.3 Inability of the Observer to Secure Confidence of the Respondent.................................................573
20.4.1.4 Bias of the Observer................................................................................................................................573
20.4.1.5 Variable Competence of the Observers................................................................................................573
20.4.2 Missing Values........................................................................................................................................................573
20.4.2.1 Approaches for Missing Values............................................................................................................ 574
20.4.2.2 Handling Nonresponse..........................................................................................................................575
20.4.2.3 Imputations..............................................................................................................................................576
20.4.2.4 Intention-to-Treat (ITT) Analysis..........................................................................................................576
20.4.3 Lack of Standardization in Values........................................................................................................................578
20.4.3.1 Standardization Methods Already Described....................................................................................578
20.4.3.2 Standardization for Calculating Adjusted Rates................................................................................578
20.4.3.3 Standardized Mortality Ratio................................................................................................................579
References........................................................................................................................................................................................580
Exercises...........................................................................................................................................................................................581

21. Statistical Fallacies........................................................................................................................................................................583


21.1 Problems with the Sample..................................................................................................................................................583
21.1.1 Biased Sample..........................................................................................................................................................583
21.1.1.1 Survivors..................................................................................................................................................584
21.1.1.2 Volunteers.................................................................................................................................................584
21.1.1.3 Clinic Subjects..........................................................................................................................................584
21.1.1.4 Publication Bias.......................................................................................................................................585
21.1.1.5 Inadequate Specification of the Sampling Method............................................................................585
21.1.1.6 Abrupt Series...........................................................................................................................................585
21.1.2 Inadequate Size of Sample.....................................................................................................................................585
21.1.2.1 Size of Sample Not Adequate................................................................................................................585
21.1.2.2 Problems with Calculation of Sample Size..........................................................................................586
21.1.3 Incomparable Groups.............................................................................................................................................586
21.1.3.1 Differential in Group Composition......................................................................................................587
21.1.3.2 Differential Compliance.........................................................................................................................588
21.1.3.3 Variable Periods of Exposure................................................................................................................588
21.1.3.4 Improper Denominator..........................................................................................................................589
21.1.4 Mixing of Distinct Groups.....................................................................................................................................590
21.1.4.1 Effect on Regression................................................................................................................................590
21.1.4.2 Effect on Shape of the Distribution......................................................................................................591
21.1.4.3 Lack of Intragroup Homogeneity.........................................................................................................591
21.2 Inadequate Analysis............................................................................................................................................................592
21.2.1 Ignoring Reality......................................................................................................................................................592
21.2.1.1 Looking for Linearity.............................................................................................................................592
21.2.1.2 Overlooking Assumptions.....................................................................................................................592
21.2.1.3 Selection of Inappropriate Variables....................................................................................................593
Contents xxvii

21.2.1.4 Area under the (Concentration) Curve................................................................................................593


21.2.1.5 Further Problems with Statistical Analysis.........................................................................................594
21.2.1.6 Anomalous Person-Years.......................................................................................................................594
21.2.1.7 Problems with Intention-to-Treat Analysis and Equivalence...........................................................595
21.2.2 Choice of Analysis..................................................................................................................................................595
21.2.2.1 Mean or Proportion?...............................................................................................................................595
21.2.2.2 Forgetting Baseline Values.....................................................................................................................596
21.2.3 Misuse of Statistical Packages...............................................................................................................................596
21.2.3.1 Overanalysis............................................................................................................................................597
21.2.3.2 Data Dredging.........................................................................................................................................597
21.2.3.3 Quantitative Analysis of Codes............................................................................................................597
21.2.3.4 Soft Data versus Hard Data...................................................................................................................597
21.3 Errors in Presentation of Findings....................................................................................................................................597
21.3.1 Misuse of Percentages and Means.......................................................................................................................598
21.3.1.1 Misuse of Percentages.............................................................................................................................598
21.3.1.2 Misuse of Means......................................................................................................................................599
21.3.1.3 Unnecessary Decimals...........................................................................................................................599
21.3.2 Problems in Reporting.......................................................................................................................................... 600
21.3.2.1 Incomplete Reporting............................................................................................................................ 600
21.3.2.2 Overreporting..........................................................................................................................................601
21.3.2.3 Selective Reporting.................................................................................................................................601
21.3.2.4 Self-Reporting versus Objective Measurement..................................................................................601
21.3.2.5 Misuse of Graphs....................................................................................................................................601
21.4 Misinterpretation.................................................................................................................................................................602
21.4.1 Misuse of P-Values..................................................................................................................................................602
21.4.1.1 Magic Threshold of 0.05.........................................................................................................................602
21.4.1.2 One-Tailed or Two-Tailed P-Values.......................................................................................................603
21.4.1.3 Multiple Comparisons............................................................................................................................603
21.4.1.4 Dramatic P-Values...................................................................................................................................603
21.4.1.5 P-Values for Nonrandom Sample..........................................................................................................603
21.4.1.6 Assessment of “Normal” Condition Involving Several Parameters................................................604
21.4.1.7 Absence of Evidence Is Not Evidence of Absence..............................................................................604
21.4.2 Correlation versus Cause–Effect Relationship...................................................................................................604
21.4.2.1 Criteria for Cause–Effect........................................................................................................................605
21.4.2.2 Other Considerations..............................................................................................................................606
21.4.3 Sundry Issues..........................................................................................................................................................606
21.4.3.1 Diagnostic Test is Only an Additional Adjunct..................................................................................606
21.4.3.2 Medical Significance versus Statistical Significance..........................................................................606
21.4.3.3 Interpretation of Standard Error of p......................................................................................................606
21.4.3.4 Univariate Analysis but Multivariate Conclusions............................................................................607
21.4.3.5 Limitation of Relative Risk....................................................................................................................607
21.4.3.6 Misinterpretation of Improvements.....................................................................................................607
21.4.4 Final Comments......................................................................................................................................................608
References........................................................................................................................................................................................609
Exercises........................................................................................................................................................................................... 610

Brief Solutions and Answers to the Selected Exercise.................................................................................................................. 611


Appendix A: Statistical Software......................................................................................................................................................631
Appendix B: Some Statistical Tables................................................................................................................................................637
Appendix C: Solution Illustrations Using R.................................................................................................................................. 643
Index........................................................................................................................................................................................................689
http://taylorandfrancis.com
Another random document with
no related content on Scribd:
TABLE

PROLOGUE 7
I. — DEUX HOMMES, DEUX CHIMÈRES 23
II. — LES CAVALIERS… 34
III. — … ET LEUR MONTURE 55
IV. — PROPOS ENTRE CIEL ET TERRE 64
V. — LE JOUR VIOLET 77
VI. — SUR LA PIERRE BRUNE 91
VII. — CEINTRAS ÉGARE SON OMBRE ET SA RAISON 101
VIII. — LA FACE AURÉOLÉE D’ÉTOILES 118
IX. — HEURES D’ATTENTE 130
X. — L’ÊTRE SE MONTRE 143
XI. — EXCURSIONS SOUTERRAINES 163
XII. — FAUX DÉPART 189
XIII. — L’AGONIE DE LA LUMIÈRE 206
XIV. — ÉCRIT SOUS LA DICTÉE DE LA MORT 226
ÉPILOGUE 233
ACHEVÉ D’IMPRIMER
Le vingt-sept mai mil neuf cent sept
PAR

ARRAULT ET Cie
A TOURS
pour le
MERCVRE
DE
FRANCE
*** END OF THE PROJECT GUTENBERG EBOOK LE PEUPLE DU
PÔLE ***

Updated editions will replace the previous one—the old editions will
be renamed.

Creating the works from print editions not protected by U.S.


copyright law means that no one owns a United States copyright in
these works, so the Foundation (and you!) can copy and distribute it
in the United States without permission and without paying copyright
royalties. Special rules, set forth in the General Terms of Use part of
this license, apply to copying and distributing Project Gutenberg™
electronic works to protect the PROJECT GUTENBERG™ concept
and trademark. Project Gutenberg is a registered trademark, and
may not be used if you charge for an eBook, except by following the
terms of the trademark license, including paying royalties for use of
the Project Gutenberg trademark. If you do not charge anything for
copies of this eBook, complying with the trademark license is very
easy. You may use this eBook for nearly any purpose such as
creation of derivative works, reports, performances and research.
Project Gutenberg eBooks may be modified and printed and given
away—you may do practically ANYTHING in the United States with
eBooks not protected by U.S. copyright law. Redistribution is subject
to the trademark license, especially commercial redistribution.

START: FULL LICENSE


THE FULL PROJECT GUTENBERG LICENSE
PLEASE READ THIS BEFORE YOU DISTRIBUTE OR USE THIS WORK

To protect the Project Gutenberg™ mission of promoting the free


distribution of electronic works, by using or distributing this work (or
any other work associated in any way with the phrase “Project
Gutenberg”), you agree to comply with all the terms of the Full
Project Gutenberg™ License available with this file or online at
www.gutenberg.org/license.

Section 1. General Terms of Use and


Redistributing Project Gutenberg™
electronic works
1.A. By reading or using any part of this Project Gutenberg™
electronic work, you indicate that you have read, understand, agree
to and accept all the terms of this license and intellectual property
(trademark/copyright) agreement. If you do not agree to abide by all
the terms of this agreement, you must cease using and return or
destroy all copies of Project Gutenberg™ electronic works in your
possession. If you paid a fee for obtaining a copy of or access to a
Project Gutenberg™ electronic work and you do not agree to be
bound by the terms of this agreement, you may obtain a refund from
the person or entity to whom you paid the fee as set forth in
paragraph 1.E.8.

1.B. “Project Gutenberg” is a registered trademark. It may only be


used on or associated in any way with an electronic work by people
who agree to be bound by the terms of this agreement. There are a
few things that you can do with most Project Gutenberg™ electronic
works even without complying with the full terms of this agreement.
See paragraph 1.C below. There are a lot of things you can do with
Project Gutenberg™ electronic works if you follow the terms of this
agreement and help preserve free future access to Project
Gutenberg™ electronic works. See paragraph 1.E below.
1.C. The Project Gutenberg Literary Archive Foundation (“the
Foundation” or PGLAF), owns a compilation copyright in the
collection of Project Gutenberg™ electronic works. Nearly all the
individual works in the collection are in the public domain in the
United States. If an individual work is unprotected by copyright law in
the United States and you are located in the United States, we do
not claim a right to prevent you from copying, distributing,
performing, displaying or creating derivative works based on the
work as long as all references to Project Gutenberg are removed. Of
course, we hope that you will support the Project Gutenberg™
mission of promoting free access to electronic works by freely
sharing Project Gutenberg™ works in compliance with the terms of
this agreement for keeping the Project Gutenberg™ name
associated with the work. You can easily comply with the terms of
this agreement by keeping this work in the same format with its
attached full Project Gutenberg™ License when you share it without
charge with others.

1.D. The copyright laws of the place where you are located also
govern what you can do with this work. Copyright laws in most
countries are in a constant state of change. If you are outside the
United States, check the laws of your country in addition to the terms
of this agreement before downloading, copying, displaying,
performing, distributing or creating derivative works based on this
work or any other Project Gutenberg™ work. The Foundation makes
no representations concerning the copyright status of any work in
any country other than the United States.

1.E. Unless you have removed all references to Project Gutenberg:

1.E.1. The following sentence, with active links to, or other


immediate access to, the full Project Gutenberg™ License must
appear prominently whenever any copy of a Project Gutenberg™
work (any work on which the phrase “Project Gutenberg” appears, or
with which the phrase “Project Gutenberg” is associated) is
accessed, displayed, performed, viewed, copied or distributed:
This eBook is for the use of anyone anywhere in the United
States and most other parts of the world at no cost and with
almost no restrictions whatsoever. You may copy it, give it away
or re-use it under the terms of the Project Gutenberg License
included with this eBook or online at www.gutenberg.org. If you
are not located in the United States, you will have to check the
laws of the country where you are located before using this
eBook.

1.E.2. If an individual Project Gutenberg™ electronic work is derived


from texts not protected by U.S. copyright law (does not contain a
notice indicating that it is posted with permission of the copyright
holder), the work can be copied and distributed to anyone in the
United States without paying any fees or charges. If you are
redistributing or providing access to a work with the phrase “Project
Gutenberg” associated with or appearing on the work, you must
comply either with the requirements of paragraphs 1.E.1 through
1.E.7 or obtain permission for the use of the work and the Project
Gutenberg™ trademark as set forth in paragraphs 1.E.8 or 1.E.9.

1.E.3. If an individual Project Gutenberg™ electronic work is posted


with the permission of the copyright holder, your use and distribution
must comply with both paragraphs 1.E.1 through 1.E.7 and any
additional terms imposed by the copyright holder. Additional terms
will be linked to the Project Gutenberg™ License for all works posted
with the permission of the copyright holder found at the beginning of
this work.

1.E.4. Do not unlink or detach or remove the full Project


Gutenberg™ License terms from this work, or any files containing a
part of this work or any other work associated with Project
Gutenberg™.

1.E.5. Do not copy, display, perform, distribute or redistribute this


electronic work, or any part of this electronic work, without
prominently displaying the sentence set forth in paragraph 1.E.1 with
active links or immediate access to the full terms of the Project
Gutenberg™ License.
1.E.6. You may convert to and distribute this work in any binary,
compressed, marked up, nonproprietary or proprietary form,
including any word processing or hypertext form. However, if you
provide access to or distribute copies of a Project Gutenberg™ work
in a format other than “Plain Vanilla ASCII” or other format used in
the official version posted on the official Project Gutenberg™ website
(www.gutenberg.org), you must, at no additional cost, fee or expense
to the user, provide a copy, a means of exporting a copy, or a means
of obtaining a copy upon request, of the work in its original “Plain
Vanilla ASCII” or other form. Any alternate format must include the
full Project Gutenberg™ License as specified in paragraph 1.E.1.

1.E.7. Do not charge a fee for access to, viewing, displaying,


performing, copying or distributing any Project Gutenberg™ works
unless you comply with paragraph 1.E.8 or 1.E.9.

1.E.8. You may charge a reasonable fee for copies of or providing


access to or distributing Project Gutenberg™ electronic works
provided that:

• You pay a royalty fee of 20% of the gross profits you derive from
the use of Project Gutenberg™ works calculated using the
method you already use to calculate your applicable taxes. The
fee is owed to the owner of the Project Gutenberg™ trademark,
but he has agreed to donate royalties under this paragraph to
the Project Gutenberg Literary Archive Foundation. Royalty
payments must be paid within 60 days following each date on
which you prepare (or are legally required to prepare) your
periodic tax returns. Royalty payments should be clearly marked
as such and sent to the Project Gutenberg Literary Archive
Foundation at the address specified in Section 4, “Information
about donations to the Project Gutenberg Literary Archive
Foundation.”

• You provide a full refund of any money paid by a user who


notifies you in writing (or by e-mail) within 30 days of receipt that
s/he does not agree to the terms of the full Project Gutenberg™
License. You must require such a user to return or destroy all
copies of the works possessed in a physical medium and
discontinue all use of and all access to other copies of Project
Gutenberg™ works.

• You provide, in accordance with paragraph 1.F.3, a full refund of


any money paid for a work or a replacement copy, if a defect in
the electronic work is discovered and reported to you within 90
days of receipt of the work.

• You comply with all other terms of this agreement for free
distribution of Project Gutenberg™ works.

1.E.9. If you wish to charge a fee or distribute a Project Gutenberg™


electronic work or group of works on different terms than are set
forth in this agreement, you must obtain permission in writing from
the Project Gutenberg Literary Archive Foundation, the manager of
the Project Gutenberg™ trademark. Contact the Foundation as set
forth in Section 3 below.

1.F.

1.F.1. Project Gutenberg volunteers and employees expend


considerable effort to identify, do copyright research on, transcribe
and proofread works not protected by U.S. copyright law in creating
the Project Gutenberg™ collection. Despite these efforts, Project
Gutenberg™ electronic works, and the medium on which they may
be stored, may contain “Defects,” such as, but not limited to,
incomplete, inaccurate or corrupt data, transcription errors, a
copyright or other intellectual property infringement, a defective or
damaged disk or other medium, a computer virus, or computer
codes that damage or cannot be read by your equipment.

1.F.2. LIMITED WARRANTY, DISCLAIMER OF DAMAGES - Except


for the “Right of Replacement or Refund” described in paragraph
1.F.3, the Project Gutenberg Literary Archive Foundation, the owner
of the Project Gutenberg™ trademark, and any other party
distributing a Project Gutenberg™ electronic work under this
agreement, disclaim all liability to you for damages, costs and
expenses, including legal fees. YOU AGREE THAT YOU HAVE NO
REMEDIES FOR NEGLIGENCE, STRICT LIABILITY, BREACH OF
WARRANTY OR BREACH OF CONTRACT EXCEPT THOSE
PROVIDED IN PARAGRAPH 1.F.3. YOU AGREE THAT THE
FOUNDATION, THE TRADEMARK OWNER, AND ANY
DISTRIBUTOR UNDER THIS AGREEMENT WILL NOT BE LIABLE
TO YOU FOR ACTUAL, DIRECT, INDIRECT, CONSEQUENTIAL,
PUNITIVE OR INCIDENTAL DAMAGES EVEN IF YOU GIVE
NOTICE OF THE POSSIBILITY OF SUCH DAMAGE.

1.F.3. LIMITED RIGHT OF REPLACEMENT OR REFUND - If you


discover a defect in this electronic work within 90 days of receiving it,
you can receive a refund of the money (if any) you paid for it by
sending a written explanation to the person you received the work
from. If you received the work on a physical medium, you must
return the medium with your written explanation. The person or entity
that provided you with the defective work may elect to provide a
replacement copy in lieu of a refund. If you received the work
electronically, the person or entity providing it to you may choose to
give you a second opportunity to receive the work electronically in
lieu of a refund. If the second copy is also defective, you may
demand a refund in writing without further opportunities to fix the
problem.

1.F.4. Except for the limited right of replacement or refund set forth in
paragraph 1.F.3, this work is provided to you ‘AS-IS’, WITH NO
OTHER WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED,
INCLUDING BUT NOT LIMITED TO WARRANTIES OF
MERCHANTABILITY OR FITNESS FOR ANY PURPOSE.

1.F.5. Some states do not allow disclaimers of certain implied


warranties or the exclusion or limitation of certain types of damages.
If any disclaimer or limitation set forth in this agreement violates the
law of the state applicable to this agreement, the agreement shall be
interpreted to make the maximum disclaimer or limitation permitted
by the applicable state law. The invalidity or unenforceability of any
provision of this agreement shall not void the remaining provisions.
1.F.6. INDEMNITY - You agree to indemnify and hold the
Foundation, the trademark owner, any agent or employee of the
Foundation, anyone providing copies of Project Gutenberg™
electronic works in accordance with this agreement, and any
volunteers associated with the production, promotion and distribution
of Project Gutenberg™ electronic works, harmless from all liability,
costs and expenses, including legal fees, that arise directly or
indirectly from any of the following which you do or cause to occur:
(a) distribution of this or any Project Gutenberg™ work, (b)
alteration, modification, or additions or deletions to any Project
Gutenberg™ work, and (c) any Defect you cause.

Section 2. Information about the Mission of


Project Gutenberg™
Project Gutenberg™ is synonymous with the free distribution of
electronic works in formats readable by the widest variety of
computers including obsolete, old, middle-aged and new computers.
It exists because of the efforts of hundreds of volunteers and
donations from people in all walks of life.

Volunteers and financial support to provide volunteers with the


assistance they need are critical to reaching Project Gutenberg™’s
goals and ensuring that the Project Gutenberg™ collection will
remain freely available for generations to come. In 2001, the Project
Gutenberg Literary Archive Foundation was created to provide a
secure and permanent future for Project Gutenberg™ and future
generations. To learn more about the Project Gutenberg Literary
Archive Foundation and how your efforts and donations can help,
see Sections 3 and 4 and the Foundation information page at
www.gutenberg.org.

Section 3. Information about the Project


Gutenberg Literary Archive Foundation
The Project Gutenberg Literary Archive Foundation is a non-profit
501(c)(3) educational corporation organized under the laws of the
state of Mississippi and granted tax exempt status by the Internal
Revenue Service. The Foundation’s EIN or federal tax identification
number is 64-6221541. Contributions to the Project Gutenberg
Literary Archive Foundation are tax deductible to the full extent
permitted by U.S. federal laws and your state’s laws.

The Foundation’s business office is located at 809 North 1500 West,


Salt Lake City, UT 84116, (801) 596-1887. Email contact links and up
to date contact information can be found at the Foundation’s website
and official page at www.gutenberg.org/contact

Section 4. Information about Donations to


the Project Gutenberg Literary Archive
Foundation
Project Gutenberg™ depends upon and cannot survive without
widespread public support and donations to carry out its mission of
increasing the number of public domain and licensed works that can
be freely distributed in machine-readable form accessible by the
widest array of equipment including outdated equipment. Many small
donations ($1 to $5,000) are particularly important to maintaining tax
exempt status with the IRS.

The Foundation is committed to complying with the laws regulating


charities and charitable donations in all 50 states of the United
States. Compliance requirements are not uniform and it takes a
considerable effort, much paperwork and many fees to meet and
keep up with these requirements. We do not solicit donations in
locations where we have not received written confirmation of
compliance. To SEND DONATIONS or determine the status of
compliance for any particular state visit www.gutenberg.org/donate.

While we cannot and do not solicit contributions from states where


we have not met the solicitation requirements, we know of no
prohibition against accepting unsolicited donations from donors in
such states who approach us with offers to donate.

International donations are gratefully accepted, but we cannot make


any statements concerning tax treatment of donations received from
outside the United States. U.S. laws alone swamp our small staff.

Please check the Project Gutenberg web pages for current donation
methods and addresses. Donations are accepted in a number of
other ways including checks, online payments and credit card
donations. To donate, please visit: www.gutenberg.org/donate.

Section 5. General Information About Project


Gutenberg™ electronic works
Professor Michael S. Hart was the originator of the Project
Gutenberg™ concept of a library of electronic works that could be
freely shared with anyone. For forty years, he produced and
distributed Project Gutenberg™ eBooks with only a loose network of
volunteer support.

Project Gutenberg™ eBooks are often created from several printed


editions, all of which are confirmed as not protected by copyright in
the U.S. unless a copyright notice is included. Thus, we do not
necessarily keep eBooks in compliance with any particular paper
edition.

Most people start at our website which has the main PG search
facility: www.gutenberg.org.

This website includes information about Project Gutenberg™,


including how to make donations to the Project Gutenberg Literary
Archive Foundation, how to help produce our new eBooks, and how
to subscribe to our email newsletter to hear about new eBooks.

You might also like